| Literature DB >> 28360885 |
Shu Zhu1, Jun Ge2, Zhongyang Liu1, Liang Liu3, Da Jing4, Mingzi Ran5, Meng Wang6, Liangliang Huang1, Yafeng Yang1, Jinghui Huang1, Zhuojing Luo1.
Abstract
Circadian rhythm (CR) plays a critical role in the treatment of several diseases. However, the role of CR in the treatment of peripheral nerve defects has not been studied. It is also known that the pulsed electromagnetic fields (PEMF) can provide a beneficial microenvironment to quicken the process of nerve regeneration and to enhance the quality of reconstruction. In this study, we evaluate the impact of CR on the promoting effect of PEMF on peripheral nerve regeneration in rats. We used the self-made "collagen-chitosan" nerve conduits to bridge the 15-mm nerve gaps in Sprague-Dawley rats. Our results show that PEMF stimulation at daytime (DPEMF) has most effective outcome on nerve regeneration and rats with DPEMF treatment achieve quickly functional recovery after 12 weeks. These findings indicate that CR is an important factor that determines the promoting effect of PEMF on peripheral nerve regeneration. PEMF exposure in the daytime enhances the functional recovery of rats. Our study provides a helpful guideline for the effective use of PEMF mediations experimentally and clinically.Entities:
Keywords: chronotherapy; circadian rhythm; functional recovery; nerve regeneration; peripheral nerves; pulsed electromagnetic fields
Year: 2017 PMID: 28360885 PMCID: PMC5350136 DOI: 10.3389/fneur.2017.00101
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1The general structure (A) and microstructural appearance of chitosan-collagen conduit under scanning electron microscopy (B–D) were shown. The schematic illustration of the device used to expose experimental animals to pulsed electromagnetic fields (PEMF) was shown (E). It included in a PEMF generator and several identical Helmholtz coils with 800 mm coil diameters. The coils were wired to a pulse generator, which produced an electromagnetic field signal with a frequency of 2 Hz, produced the magnetic field with amplitude of 0.3 mT, and a pulse duration of 20 ms and placed with interval of 304 mm in the same axis. Each coil was composed by enameled coated copper wire with 0.8-mm diameter. This ubiety of three coils reduced the deviation of the magnetic field intensity that made the magnetic field more uniform.
Number of rats per group and time point allocated to different assessments.
| CF group | DPEMF group | NPEMF group | |
|---|---|---|---|
| Expression of regeneration-related genes | 6 (NO.13/56/89/103/134/168) | 6 (NO. 22/46/81/119/141/178) | 6 (NO.31/96/100/105/153/183) |
| Expression of regeneration-related genes | 6 (NO.2/16/37/48/101/121) | 6 (NO.1/27/65/71/151/189) | 6 (NO.11/69/72/135/162/165) |
| Axonal regeneration and functional recovery assessment | 6 (NO.18/61/67/91/98/193) | 6 (NO.9/33/49/145/157/198) | 6 (NO. 38/44/77/92/139/171) |
| Fluoro-Gold (FG) retrograde tracing assessment | 6 (NO.20/35/60/83/109/146) | 6 (NO.25/51/78/104/140/192) | 6 (NO.4/58/84/123/158/170) |
| Immunohistochemistry assessment | 6 (NO.23/59/107/147/152/166) | 6 (NO.5/17/32/80/111/142) | 6 (NO.15/76/99/155/156/187) |
| Axonal regeneration and functional recovery assessment | 6 (NO.8/10/86/125/143/154) | 6 (NO.19/41/95/113/149/160) | 6 (NO.7/66/85/88/126/150) |
| Immunohistochemistry assessment | 6 (NO.30/52/128/130/137/174) | 6 (NO.28/45/116/132/161/185) | 6 (NO.12/39/55/57/114/177) |
| FG retrograde tracing assessment | 6 (NO.26/117/159/164/167/195) | 6 (NO.14/68/106/131/148/163) | 6 (NO.34/54/90/108/120/122) |
| Axonal regeneration and functional recovery assessment | 6 (NO. 6/29/63/115/118/136) | 6 (NO. 21/73/94/112/124/127) | 6 (NO.24/43/97/129/172/173) |
| FG retrograde tracing assessment | 6 (NO. 36/47/53/87/93/110) | 6 (NO. 40/79/82/181/182/191) | 6 (NO. 50/64/70/133/138/197) |
| Immunohistochemistry assessment | 6 (NO. 42/74/75/169/176/196) | 6 (NO.62/102/144/175/188/190) | 6 (NO.3/179/180/184/186/194) |
| Total number | 66 | 66 | 66 |
.
Primer sequences used for the real-time PCR.
| Target gene | GenBank accession no. | Direction | Sequence | |
|---|---|---|---|---|
| β-Actin | NM_031144.2 | Upper | 5′ ATGAAGATCCTGACCGA 3′ | |
| Lower | 5′ GCTCATTGCCGATAGTG 3′ | |||
| Nerve growth factor | XM_227525.6 | Upper | 5′ TTTTGCCTTTGCCTGGT 3′ | |
| Lower | 5′ GTTGATTGGCTGTGTCC 3′ | |||
| Brain-derived neurotrophic factor | NM_012513.4 | Upper | 5′ GCCCAACGAAGAAAACC 3′ | |
| Lower | 5′ CCAGCAGAAAGAGCAGA 3′ | |||
| S100b | NM_013191.1 | Upper | 5′ ATCAGGTGCTCTCTTGAA 3′ | |
| Lower | 5′ GTAACAGTGAAGCGACC 3′ |
Figure 2Morphological appearance of regenerated nerves in each group. The representative toluidine blue staining of regenerated axons (A–C) in the midst of conduit in the DPEMF group (A), NPEMF group (B), and CF group (C) at 12 weeks after surgery, respectively. The representative electron micrographs of regenerated axons (D–F) and myelin sheath (G–I) in the midst of conduit in the DPEMF group (D,G), NPEMF group (E,H), and CF group (F,I) at 12 weeks postoperatively.
Figure 3Morphometric assessments of regenerated nerves in each group. The cross-sectional area of regenerated nerve (A), quantification of the myelinated axons (B), the diameter of myelinated axons (C), and G-ratios (D) in the midst portion of conduit (A–D). All data were expressed as the mean ± SEM. *p < 0.05 for comparison with CF group, #p < 0.05 for comparison with NPEMF group.
Figure 4Double-immunohistochemical staining for S-100 and NF200 in each group. The representative images of regenerated nerves in the midst of conduit in the DPEMF group (A–C), NPEMF group (D–F), and CF group (G–I), postoperatively.
Figure 5The Sciatic function index and walking mean latency in each group. The operative left footprints [(A) (a–c)] in the DPEMF group [(A) (a)], NPEMF group [(A) (b)], and CF group [(A) (c)] at 12 weeks postoperatively. All data were expressed as the mean ± SEM (B,C). *p < 0.05 for comparison with CF group, #p < 0.05 for comparison with NPEMF group.
Figure 6The electrophysiological assessments in each group. The representative recordings are shown from the DPEMF group (A), the NPEMF group (B), and the CF group (C) at 12 weeks postoperatively. The peak amplitude of compound muscle action potentials (CMAPs) (D), NCV value (E), and latency of CMAP onset (F) recorded at 4, 8, and 12 weeks after surgery. All data were expressed as the mean ± SEM. *p < 0.05 for comparison with CF group, #p < 0.05 for comparison with NPEMF group.
Figure 7Fluoro-Gold (FG) retrograde tracing in each group. FG-labeled motoneurons in spinal cord (A–C) and sensory neurons in dorsal root ganglia (D–F) in the DPEMF group (A,D), NPEMF group (B,E), and CF group (C,F) at 12 weeks after surgery. The average number of FG-positive motoneurons and sensory neurons in each group were shown in panels (G) and (H), respectively. All data were expressed as the mean ± SEM. *p < 0.05 for comparison with CF group, #p < 0.05 for comparison with CFO group.
Figure 8Histological analysis of target gastrocnemius muscle in each group. Representative light micrographs of the transverse-sectioned gastrocnemius muscle following HE staining for the operated limb in the DPEMF group (A), NPEMF group (B), and CF group (C) at 12 weeks postoperatively. The average percentage of muscle fiber in each group was shown in panel (D). All data were expressed as the mean ± SEM. *p < 0.05 for comparison with CF group, #p < 0.05 for comparison with CFO group.
Figure 9The mRNA levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), VEGF, and S-100. The mRNA levels of (A) NGF, (B) BDNF, and (C) S-100 are determined for the DPEMF group, NPEMF group, and CF group at 1 and 3 weeks after surgery. Each test was repeated three times. All data were expressed as the mean ± SEM. *p < 0.05 for comparison with CF group, #p < 0.05 for comparison with CFO group.